Clinical Trial

Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease

Study acronym: ECG-AID
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 25, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
Atrial fibrillation is an abnormal beating of the heart that can lead to stroke or heart failure. Structural heart diseases are conditions that affect the heart valves or heart muscle and can cause permanent heart damage if left untreated. Sometimes people have atrial fibrillation or structural heart disease and do not know it. The purpose of this study is to evaluate two devices that can predict who has or may develop atrial fibrillation or structural heart disease based on the results of an electrocardiogram.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05442203
Lead Sponsor Tempus AI
Conditions Atrial Fibrillation, Structural Heart Disease
Enrollment 1,000 participants
Start Date 2022-09-07
Primary Completion 2025-07 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2024-07-25